ASPEN HEALTHCARE LIMITED
Get an alert when ASPEN HEALTHCARE LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-08-09 (in 3mo)
Last made up 2025-07-26
Watchouts
None on the register
Cash
—
Latest balance sheet
Net assets
£15M
+160.6% vs 2023
Employees
0
Average over period
Profit before tax
£10M
+144.4% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | — | — | |
| Profit before tax | -£21,415,000 | £9,516,000 | |
| Net profit | -£21,415,000 | £9,516,000 | |
| Cash | — | — | |
| Total assets less current liabilities | £5,924,000 | £15,440,000 | |
| Net assets | £5,924,000 | £15,440,000 | |
| Equity | £5,924,000 | £15,440,000 | |
| Average employees | 0 | 0 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The company is currently not trading, however the directors have assessed its financial position and confirm that the company holds sufficient net assets to meet its liabilities as they fall due. As a result, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence from the period ending 12 months from the date of their approval of these financial statements.”
Group structure
- ASPEN HEALTHCARE LIMITED · parent
- Aspen Leasing 100%
- Cancer Centre London LLP 0%
- Edinburgh Medical Services Limited 100%
- Highgate Hospital LLP 100%
- Hillside Holdings Limited 100%
- Hillside Hospital Limited 100%
- Holly House Hospital Limited 100%
- Holly House Hospital Oncology LLP 100%
- Parkside Hospital Limited 100%
- Parkside IHL Scanning Services LLP 51.8%
- The Edinburgh Clinic Limited 100%
Significant events
- “On 31 January 2025, Aspen Healthcare Limited sold it's investment in Parkside IHL Scanning Services LLP to Integrated Clinical Oncology Network UK Limited (ICON) for £0.6m and profit of disposal of £0.6m.”
- “On 4 March 2025, the strike-off process has been formally completed for the following subsidiary entities: Holly House Hospital Limited, Holly House Hospital Oncology LLP, Parkside Hospital Limited and The Edinburgh Clinic Limited.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 25 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| THOMSON, Iben | Secretary | 2023-09-06 | — | — |
| BAKER, Paul Martin | Director | 2025-12-10 | Jun 1969 | British |
| THOMSON, Iben Charlotte | Director | 2024-08-20 | May 1968 | British |
Show 25 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ANDERSON, Robin Dafydd | Secretary | 2019-07-01 | 2021-09-30 |
| HETHERINGTON, Paul | Secretary | 2018-12-26 | 2019-07-01 |
| SHIELS, Desmond Anthony | Secretary | 2002-04-12 | 2018-12-26 |
| WHITEHAND, Neil William | Secretary | 1998-02-27 | 2002-04-12 |
| WOTHERSPOON, John Mcmurdo | Secretary | 1998-02-27 | 1998-02-27 |
| ALNERY INCORPORATIONS NO 1 LIMITED | Corporate Nominee Secretary | 1997-11-25 | 1998-02-27 |
| ANDERSON, Robin Dafydd | Director | 2019-07-01 | 2022-03-31 |
| BARBER, Fiona | Director | 2017-06-06 | 2022-09-28 |
| BLACKWELL-FROST, Chris | Director | 2022-02-11 | 2022-11-30 |
| BROKE, Michael Haviland Adlington | Director | 1998-04-27 | 2000-04-06 |
| DAVIS, Michael Brenden | Director | 2019-01-06 | 2021-08-06 |
| DILLON, Jennifer Ann | Director | 2022-09-28 | 2022-11-30 |
| HETHERINGTON, Paul | Director | 2018-12-24 | 2019-07-01 |
| KOPSER, Mark Anthony | Director | 2000-05-02 | 2018-08-17 |
| LAMBERT, Amanda | Director | 2022-11-30 | 2024-10-31 |
| LEWSEY, David | Director | 2008-03-18 | 2016-12-23 |
| LYNN, Matthew | Director | 2024-08-01 | 2025-12-10 |
| MCCANN, Patricia | Director | 2001-08-22 | 2009-12-31 |
| SHIELS, Desmond Anthony | Director | 2006-10-20 | 2018-12-26 |
| SMITH, Caroline Naomi | Director | 2022-11-30 | 2024-09-03 |
| STEEN, Donald Ellsworth | Director | 2000-04-06 | 2014-05-13 |
| SYMONDSON, David Warwick | Director | 1998-03-04 | 2000-04-06 |
| WOTHERSPOON, John Mcmurdo | Director | 1998-02-27 | 2002-05-15 |
| ALNERY INCORPORATIONS NO 1 LIMITED | Corporate Nominee Director | 1997-11-25 | 1998-02-27 |
| ALNERY INCORPORATIONS NO 2 LIMITED | Corporate Nominee Director | 1997-11-25 | 1998-02-27 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Nuffield Health | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-09-30 | Active |
| Global Healthcare Partners Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2021-09-30 |
Filing timeline
Last 20 of 187 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-12-12 | AP01 | officers | Appoint person director company with name date | |
| 2025-12-12 | TM01 | officers | Termination director company with name termination date | |
| 2025-08-28 | AA | accounts | Accounts with accounts type full | |
| 2025-07-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-17 | AD04 | address | Move registers to registered office company with new address | |
| 2025-06-08 | AD02 | address | Change sail address company with old address new address | |
| 2024-11-04 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-17 | AA | accounts | Accounts with accounts type full | |
| 2024-09-03 | TM01 | officers | Termination director company with name termination date | |
| 2024-09-03 | CH01 | officers | Change person director company with change date | |
| 2024-08-29 | AP01 | officers | Appoint person director company with name date | |
| 2024-08-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-02 | AP01 | officers | Appoint person director company with name date | |
| 2023-12-18 | AA | accounts | Accounts with accounts type full | |
| 2023-09-08 | AP03 | officers | Appoint person secretary company with name date | |
| 2023-08-09 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-12-16 | AA | accounts | Accounts with accounts type full | |
| 2022-12-01 | TM01 | officers | Termination director company with name termination date | |
| 2022-12-01 | TM01 | officers | Termination director company with name termination date | |
| 2022-12-01 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
—
Not reported
-
Net assets
+160.6%
£5,924,000 £15,440,000
-
Employees
—
Not reported
-
Profit before tax
+144.4%
-£21,415,000 £9,516,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers